| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.05 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.067 | 0.06 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.06 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.06 |